01 164ASTRAZENECA AB
01 110973836*PED
02 111826376*PED
03 111903955*PED
04 156515117
05 76515117*PED
06 27456254
07 27456254*PED
08 27851502
09 27851502*PED
10 137919598
11 77919598*PED
12 48221786
13 28221786*PED
14 68329648
15 28329648*PED
16 88361972
17 28361972*PED
18 28431685
19 28431685*PED
20 28461105
21 28461105*PED
22 158501698
23 78501698*PED
24 68628799
25 78685934
26 78685934*PED
27 88716251
28 28716251*PED
29 28721615
30 28906851
31 99616028
32 110973836
33 111826376
34 111903955
35 28721615*PED
36 28906851*PED
37 29238076
38 59616028*PED
01 28Y
02 136Blank
01 61Y
02 103Blank
01 22024-04-15
02 42025-04-13
03 22025-06-30
04 62025-07-13
05 152025-10-04
06 42025-10-13
07 22025-12-30
08 72026-04-04
09 82026-08-18
10 42027-02-18
11 152027-06-20
12 72027-12-20
13 202028-03-21
14 22028-08-19
15 62028-09-21
16 22029-02-19
17 132029-12-16
18 22030-01-18
19 72030-05-26
20 72030-06-16
21 22030-07-18
22 92030-11-12
23 72030-11-26
24 52031-05-12
25 12039-07-18
26 12040-01-18
27 22040-03-09
28 22040-09-09
Patent Expiration Date : 2030-05-26
US Patent Number : 8685934
Drug Substance Claim :
Drug Product Claim :
Application Number : 202293
Patent Use Code : U-1522
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2030-05-26
Patent Expiration Date : 2025-10-04
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 6515117
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 205649
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2025-10-04
Patent Expiration Date : 2025-10-04
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 6515117
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 205649
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2025-10-04
Patent Expiration Date : 2027-06-20
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8501698
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205649
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2027-06-20
Patent Expiration Date : 2025-10-04
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 6515117
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 205649
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2025-10-04
Patent Expiration Date : 2027-06-20
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8501698
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205649
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2027-06-20
Patent Expiration Date : 2030-05-26
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8685934
Drug Substance Claim :
Drug Product Claim :
Application Number : 205649
Patent Use Code : U-1522
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2030-05-26
Patent Expiration Date : 2026-08-18
US Patent Number : 8906851
Drug Substance Claim :
Drug Product Claim :
Application Number : 202293
Patent Use Code : U-2139
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-08-18
Patent Expiration Date : 2024-04-15
US Patent Number : 9238076
Drug Substance Claim :
Drug Product Claim :
Application Number : 202293
Patent Use Code : U-2139
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2024-04-15
Patent Expiration Date : 2026-08-18
US Patent Number : 8329648
Drug Substance Claim :
Drug Product Claim :
Application Number : 202293
Patent Use Code : U-2213
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-08-18
LOOKING FOR A SUPPLIER?
